|
|
Article: HORMONE THERAPY TREATMENTS CARRY NEW WARNINGS THEY ARE IN RESPONSE TO A STUDY THAT FOUND AN INCREASED RISK OF HEART DISEASE AND BREAST CANCER FROM USING THE THERAPIES.(FRONT)
- Article from:
- The Wisconsin State Journal (Madison, WI)
- Article date:
- January 9, 2003
CopyrightCOPYRIGHT 2003 Capital Newspapers. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: Darlene Superville Associated Press
WASHINGTON -- The government announced new warnings Wednesday on the labels for hormone replacement therapies and advised millions of post-menopausal women to consult their doctors about whether to continue treatment.
The Food and Drug Administration acted after reviewing data from a landmark study that found that the increased risk of heart disease and breast cancer from using therapies combining the hormones estrogen and progestin far outweighed any health benefits. The government abruptly halted that study last July.
The FDA approved new labels for Wyeth Pharmaceuticals, maker of the best-selling ...